Danish pharma company restructures amid US and EU patent disputes
Gibson Dunn & Crutcher and Davis Polk & Wardwell have helped Danish drugs manufacturer Forward Pharma complete a corporate restructuring, which the company says should guard it against the outcome of a number of patent disputes in the US and Europe.
To read more
Subscribe to Global Restructuring Review
Subscribe & start reading now!
GRR is a daily information service providing cross-border insolvency and restructuring news, features and events.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10